PropertyValue
?:abstract
  • We think that thalassemia is not necessarily a cause of aggravation of the clinical course in COVID‐19; however, certain key factors must be considered, such as the anemic condition, the likely pathogenic role of the virus on hemoglobin, and the hypercoagulable state to prevent any complications.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1002/ccr3.3275
?:journal
  • Clin_Case_Rep
?:license
  • cc-by-nc-nd
?:pdf_json_files
  • document_parses/pdf_json/371b228b5cae0af194ddf66af00b3af6337ff1af.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7646639.xml.json
?:pmcid
?:pmid
?:pmid
  • 33173583.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • COVID‐19 pneumonia and pulmonary microembolism in a patient with B‐thalassemia major
?:type
?:year
  • 2020-09-25

Metadata

Anon_0  
expand all